Intelligence / Healthtech / FDA 510(k) Clearances / Berkeley Advanced Biomaterials
Berkeley Advanced Biomaterials
27 Aug 2026: Device cleared · Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP). Recorded in the openFDA device 510(k) data.
- Decided
- 27 Aug 2026
- Device
- Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP)
- Specialty
- Unknown
- Country
- United States
- Location
- Berkeley, CA
- Clearance type
- Traditional
- 510(k) number
- K260711
- Submitted
- 2026-03-05
A clearance starts commercialisation: distribution, reimbursement, software and sales hires.
- 268 added in the 30 days to 9 Nov 2026.
- Cardiovascular leads with 122 clearances, then Radiology (107).
Find the decision makers at Berkeley Advanced Biomaterials
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Berkeley Advanced Biomaterials in our registers.
More in Unknown
FDA 510(k) Clearances
Source: openFDA device 510(k) data, data to 9 Nov 2026. Devices FDA found substantially equivalent and cleared for the US market. Decision dates as published by FDA. AOS shows what the public record says; it does not verify or endorse the company.